FDA Drug Application (206910) for JADENU by NOVARTIS PHARMS CORP

Back to FDA Applications sponsored by NOVARTIS PHARMS CORP

Application Number206910
Product Number001
FormTABLET;ORAL
Dosage90MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameJADENU
Active IngredientDEFERASIROX

Active IngredientCount
List of drugs with Active Ingredient DEFERASIROX3


Back to FDA Applications sponsored by NOVARTIS PHARMS CORP